Camber Finasteride 5mg Recall: Tablet Thickness Issue
Camber Pharmaceuticals recalls specific lots of Finasteride Tablets USP 5 mg due to failed specifications. Check your bottle's lot number and expiration date.
Recall notice
Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.
Contact the company
What happened, in plain English
Camber Pharmaceuticals, Inc. is recalling one lot of Finasteride Tablets, USP 5 mg in 90-count bottles because the tablets were found to be twice the thickness as expected. This recall affects approximately 20,412 units distributed only in New Jersey. The manufacturer is Hetero Drugs Ltd. - Unit 1. Read more at govinfonow.com/recall/42100-camber-finasteride-5mg-recall-tablet-thickness-issue.
Source Summary by GovInfoNow · govinfonow.com/recall/42100-camber-finasteride-5mg-recall-tablet-thickness-issue · Updated October 11, 2026 · FDA enforcement record: FDA #D-0453-2017
Cite this page
“Camber Finasteride 5mg Recall: Tablet Thickness Issue.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/42100-camber-finasteride-5mg-recall-tablet-thickness-issue. Based on FDA recall #D-0453-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0453-2017%22&limit=1).
Why it’s dangerous
The recalled tablets failed specification requirements by being twice the thickness of standard tablets. The record does not specify if this physical difference causes dosage errors, swallowing difficulties, or other health risks.
Who’s affected
Patients in New Jersey who purchased Finasteride Tablets USP 5 mg from pharmacies during the distribution period are likely affected. Individuals possessing the specific lot number FIN16002 with an expiration date of 03/2018 are at risk.
How to tell if you have this one
Check your medication bottle for NDC 31722-525-90 and Lot # FIN16002 with an expiration date of 03/2018. The product is Finasteride Tablets, USP 5 mg in 90-count bottles, manufactured by Hetero Drugs Ltd. - Unit 1 for Camber Pharmaceuticals, Inc.
- Brand
Camber Pharmaceuticals- Category
Drug
Where it went and when
Where it was distributed
Distributed in New Jersey.
FDA distribution: “NJ only.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: New Jersey.
Recall timeline
FDA terminated this recall 6 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Where was this product sold?
The distribution pattern for this recall was limited to New Jersey only.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0453-2017 (December 29, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0453-2017 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.